WilliamRSunterJr.MD

PubMed

• Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
  Miller DH Fox RJ Phillips JT Hutchinson M Havrdova E Kita M Wheeler-Kingshott CA Tozer DJ MacManus DG Yousry TA Goodsell M Yang M Zhang R Viglietta V Daw...> ;Neurology. 2015 Mar 17
• Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
  Salloway S Sperling R Fox NC Blennow K Klunk W Raskind M Sabbagh M Honig LS Porsteinsson AP Ferris S Reichert M Ketter N Nejadnik B Guenzler V Miloslavsk...> ;N Engl J Med. 2014 Jan 23
• Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin((R))) injections in blepharospasm.
  Truong DD Gollomp SM Jankovic J LeWitt PA Marx M Hanschmann A Fernandez HH> ;J Neural Transm. 2013 Sep
• Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
  Fox RJ Miller DH Phillips JT Hutchinson M Havrdova E Kita M Yang M Raghupathi K Novas M Sweetser MT Viglietta V Dawson KT> ;N Engl J Med. 2012 Sep 20
• Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN(R), botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.
  Comella CL Jankovic J Truong DD Hanschmann A Grafe S> ;J Neurol Sci. 2011 Sep 15
• Join now to see all

Journal Articles

• Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease  
  Hauser, RA et al., Movement Disorders, 3/24/2009